BioRegenx, Inc.
BRGX
$0.0129
$0.001917.27%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.89% | -404.23% | -258.31% | 117.67% | -323.72% |
| Total Depreciation and Amortization | -33.98% | 334.88% | 5,658.33% | -400.00% | 0.00% |
| Total Amortization of Deferred Charges | -65.32% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.83% | 566.84% | -39.23% | -75.72% | -- |
| Change in Net Operating Assets | -70.28% | -34.64% | 21.75% | 4,339.02% | 92.56% |
| Cash from Operations | 90.21% | -961.08% | -96.82% | 510.83% | 56.27% |
| Capital Expenditure | -100.00% | 167.81% | -1,244.75% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 199.99% | -- | -- | -- |
| Cash from Investing | -100.00% | 199.00% | -37,135.80% | -- | -- |
| Total Debt Issued | 127.64% | -132.24% | 4,880.47% | -82.02% | 9,000.00% |
| Total Debt Repaid | -116.61% | 167.76% | -163.45% | 887.98% | -357.50% |
| Issuance of Common Stock | -- | -- | -- | -- | -84.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | -- | -- | -- |
| Cash from Financing | 100.25% | -197.88% | 2,985.14% | -666.84% | -71.63% |
| Foreign Exchange rate Adjustments | -620.00% | -50.00% | -- | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.36% | -407.14% | -102.01% | 433.39% | 25.30% |
